These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 5788791)
41. [Exoprotease properties of Bacillus subtilis var. amyloliquefaciens capable of coagulating blood plasma]. Al'-Nuri MA; Otroshko TA; Egorov NS Mikrobiologiia; 1978; 47(5):900-5. PubMed ID: 30884 [TBL] [Abstract][Full Text] [Related]
42. Effect of beta-propiolactone on routine biochemical investigations. Dooley BJ; Harling NP; Lloyd G; van Heyningen C Med Lab Sci; 1985 Oct; 42(4):318-21. PubMed ID: 4079681 [No Abstract] [Full Text] [Related]
43. Fibrinogen Troyes--fibrinogen Metz. Two new cases of congenital dysfibrinogenemia. Soria J; Soria C; Samama M; Poirot E; Kling C Thromb Diath Haemorrh; 1972 Jul; 27(3):619-33. PubMed ID: 4662617 [No Abstract] [Full Text] [Related]
44. Effect of beta-propiolactone on tick-borne encephalitis virus. SEMENOV BF; REZEPOVA AI Probl Virol; 1961; 6():467-70. PubMed ID: 14039130 [No Abstract] [Full Text] [Related]
45. Effect of beta-propiolactone on some routine haematological tests. Atrah HI; Allardyce M; Davidson RJ Med Lab Sci; 1988 Oct; 45(4):308-11. PubMed ID: 3268715 [No Abstract] [Full Text] [Related]
46. Antiveratrinic activity of lactones and peroxides. WENZEL DG; SMITH CM J Am Pharm Assoc Am Pharm Assoc; 1958 Apr; 47(4):269-72. PubMed ID: 13538802 [No Abstract] [Full Text] [Related]
47. Blood coagulation and acute iron toxicity. Reversible iron-induced inactivation of serine proteases in vitro. Rosenmund A; Haeberli A; Straub PW J Lab Clin Med; 1984 Apr; 103(4):524-33. PubMed ID: 6421970 [TBL] [Abstract][Full Text] [Related]
48. [Principles of selective inactivation of the viral genome. III. Kinetics of the inactivation of bacteriophage MS2 infectivity by beta-propiolactone]. Budovskiĭ EI; Zalesskaia MA Mol Biol (Mosk); 1985; 19(4):1139-47. PubMed ID: 4047036 [TBL] [Abstract][Full Text] [Related]
49. [Stability of coagulation parameters: review of available data]. Mauge L; Alhenc-Gelas M Ann Biol Clin (Paris); 2014; 72(2):141-5. PubMed ID: 24736134 [TBL] [Abstract][Full Text] [Related]
50. Platelet quality after washing: the effect of storage time before washing. Tynngård N; Trinks M; Berlin G Transfusion; 2010 Dec; 50(12):2745-52. PubMed ID: 20576018 [TBL] [Abstract][Full Text] [Related]
51. Alkaloids of tobacco and blood coagulation: effect of nicotine on thrombin and fibrinogen. Singh JM; Singh MD Clin Toxicol; 1975; 8(1):43-52. PubMed ID: 1137933 [TBL] [Abstract][Full Text] [Related]
52. [Varying effectiveness of beta-propiolacton in sterilisation of esterase-active and esterase-inactive serum and plasma]. Stephan W; Haug E Zentralbl Bakteriol Orig; 1970; 215(3):381-5. PubMed ID: 4321704 [No Abstract] [Full Text] [Related]
53. Beta-propiolactone as an agent for enzyme sterilization. Stokes KJ J Clin Pathol; 1971 Oct; 24(7):658-60. PubMed ID: 5118830 [TBL] [Abstract][Full Text] [Related]
54. [Elimination of complement fixation of gamma-globulin by chemical modification with beta-propiolactone]. Stephan W Z Klin Chem Klin Biochem; 1969 May; 7(3):282-6. PubMed ID: 4187787 [No Abstract] [Full Text] [Related]
55. Preanalytical aspects of coagulation testing. Narayanan S Haematologica; 1995; 80(2 Suppl):1-6. PubMed ID: 7628761 [No Abstract] [Full Text] [Related]
56. Clotting of bovine fibrinogen by liver transamidase. Farrell J; Laki K Blood; 1970 Jun; 35(6):804-8. PubMed ID: 5427250 [No Abstract] [Full Text] [Related]
57. Effects of propiolactone on rat fibrocytes. Powell AK Nature; 1966 Jan; 209(5018):77-8. PubMed ID: 5925335 [No Abstract] [Full Text] [Related]
58. A study of fibrinogen production by human liver slices in vitro by an immunoprecipitin method. STRAUB PW J Clin Invest; 1963 Jan; 42(1):130-6. PubMed ID: 13978783 [No Abstract] [Full Text] [Related]
59. The influence of beta-propiolactone on the coagulability of human fibrinogen. Doleschel W; Auerswald W Pharmacology; 1969; 2(1):1-8. PubMed ID: 5788791 [No Abstract] [Full Text] [Related]
60. [Influence of beta-propiolactone (BPL) on the activity of clotting factors of human plasma (experiments in vitro). 2]. Vlcková M; Sochman J Vnitr Lek; 1970 Sep; 16(9):857-61. PubMed ID: 5456349 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]